PLX icon

Protalix BioTherapeutics
PLX

Overview Fund Activity

45 hedge funds and large institutions have $8.4M invested in Protalix BioTherapeutics in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 7 closing their positions.

Holders
45
Holders Change
+1
Holders Change %
+2.27%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
12
Reduced
8
Closed
7
Calls
$98K
Puts
$10K
Net Calls
+$88K
Net Calls Change
+$63K

Top Buyers

1
Northern Trust
1
Northern Trust
Illinois
$1.38M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$2.1M
3
Morgan Stanley
3
Morgan Stanley
New York
$320K
4
Marshall Wace
4
Marshall Wace
United Kingdom
$192K
5
Jane Street
5
Jane Street
New York
$214K

Top Sellers

1
GCP
1
GSA Capital Partners
United Kingdom
$575K
2
OGF
2
Orin Green Financial
California
$135K
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$0
4
SA
4
Sanctuary Advisors
Indiana
$0
5
XT
5
XTX Topco
Cayman Islands
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
TRCT
51
Tower Research Capital (TRC)
New York
– -$5.16K -5,055 Closed
Simplex Trading
52
Simplex Trading
Illinois
– -$3K -3,414 Closed
1 2
3